Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation
- 1 November 2010
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 147 (3) , 400-407
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Interfering with disease: a progress report on siRNA-based therapeuticsNature Reviews Drug Discovery, 2007
- Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosisJournal Of Hypertension, 2006
- Network Formation and Degradation Behavior of Hydrogels Formed by Michael-Type Addition ReactionsBiomacromolecules, 2004
- Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature, 2004
- RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.2004
- siRNA for gene silencing: a route to drug target discoveryCurrent Opinion in Pharmacology, 2004
- Sustained Polymeric Delivery of Gene Silencing Antisense ODNs, siRNA, DNAzymes and Ribozymes:In VitroandIn VivoStudiesJournal of Drug Targeting, 2004
- Use of adeno-associated viral vector for delivery of small interfering RNAOncogene, 2003
- Altered Extracellular Matrix Remodeling and Angiogenesis in Sponge Granulomas of Thrombospondin 2-Null MiceThe American Journal of Pathology, 2001
- Prevention of small airway obliteration in a swine heterotopic lung allograft modelThe Journal of Heart and Lung Transplantation, 2000